China’s Zhifei will pay GSK (NYSE: GSK) about 2.3 billion pounds ($2.9 billion) for the exclusive rights to distribute GSK’s […]
GSK to Get Less from Zhifei Shingles Vaccine Deal; to Collaborate on RSV Read More »
On Wednesday, GSK (NYSE: GSK) said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory
GlaxoSmithKline (NYSE: GSK), the British drugmaker, sued Moderna (NASDAQ: MRNA) in U.S. federal court in Delaware on Tuesday, accusing it
GSK Sues Moderna Over mRNA Patent Infringement Read More »
Shares of GSK (NYSE: GSK) rose about 6% on Wednesday after the British drugmaker struck a $2.2 billion settlement over U.S.
GSK (NYSE: GSK) Stock Surges After $2.2 Billion Zantac Lawsuits Settlement Read More »
U.S. sales of RSV vaccines from GSK (NYSE: GSK) and Pfizer (NYSE: PFE) are down significantly after regulators narrowed the
Pfizer and GSK RSV Vaccine Sales Fall in US as Millions Fewer People Line Up Read More »
LONDON – On Monday, Pfizer (NYSE: PFE) won a bid in a London court to invalidate two of GSK’s (NYSE:
Pfizer Secures Legal Victory Against GSK in RSV Vaccine Patent Dispute Read More »
GSK (NYSE: GSK), Sanofi (NASDAQ: SNY), and CSL Ltd have secured $72 million from the U.S. government to ramp up
Sanofi, GSK, CSL Secure $72 Million Funding to Expand US Bird Flu Vaccine Supply Read More »
On Wednesday, GSK (NYSE: GSK), the British drugmaker, said it had agreed to settle two lawsuits in California that claimed
GSK (NYSE: GSK) Settles Two California Lawsuits Over Heartburn Drug Zantac Read More »
On Thursday, GSK (NYSE: GSK), the British drugmaker, announced positive results from a mid-stage trial of its seasonal influenza vaccine
GSK (NYSE: GSK) Advances mRNA Flu Vaccine to Late-Stage Trials Read More »
Copyright © 2024 abbonews.com
